{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:37:35Z","timestamp":1792427855157,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Generalized anxiety disorder (GAD) is a devastating mental health condition characterized by constant, uncontrolled worrying. Recent hypotheses indicate that pro-inflammatory cytokines and chemokines are potential contributors to the pathogenesis of GAD. Here, we aimed to assess the role of interleukin-2 (IL-2) and interleukin-10 (IL-10) in the pathophysiology and development of GAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study recruited 50 GAD patients diagnosed according to the DSM-5 criteria and 38 age-sex-matched healthy controls (HCs). A qualified psychiatrist evaluated all study subjects. The socio-demographic and clinical characteristics of the study population were determined using pre-structured questionnaires or interviews, and cytokine serum levels were estimated using commercially available ELISA kits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We observed reduced serum IL-10 levels in GAD patients compared to HCs (33.69\u2009\u00b1\u20091.37 pg\/ml vs. 44.12\u2009\u00b1\u20093.16 pg\/ml). Also, we observed a significant negative correlation between altered IL-10 levels and GAD-7 scores (<jats:italic>r<\/jats:italic>=-0.315, <jats:italic>p<\/jats:italic>\u2009=\u20090.039). Moreover, IL-10 serum measurement exhibited good predictive value in receiver operating characteristics (ROC) analysis with an area under the curve (AUC) value of 0.793 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) with 80.65% sensitivity and 62.79% specificity at a cutoff value of 33.93 pg\/ml. Conversely, we noticed elevated serum IL-2 levels in GAD patients than in HCs (14.81\u2009\u00b1\u20092.88 pg\/ml vs. 8.08\u2009\u00b1\u20091.1 pg\/ml); however, it failed to maintain any significant association with GAD-7 scores, implying that IL-2 might not be involved in GAD pathogenesis. The lower AUC value (0.640; <jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05) exhibited by IL-2 serum measurement in ROC analysis further supported that IL-2 might not be associated with GAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study provides new insights into the complex interplay between anti-inflammatory cytokines and GAD pathogenesis. Based on the present findings, we can assume that IL-10 but not IL-2 may be associated with the pathophysiology and development of GAD. However, further research with a larger population size and longitudinal design is required to confirm the potential diagnostic efficacy of IL-10.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-024-05911-z","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:02:56Z","timestamp":1718877776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study"],"prefix":"10.1186","volume":"24","author":[{"given":"Nisat","family":"Sarmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S. M.","family":"Roknuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapty","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamun","family":"-or-Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MMA Shalahuddin","family":"Qusar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitesh Chandra","family":"Bachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Rahman","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Rabiul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobaer","family":"Al Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"6","key":"5911_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14737175.2023.2211767","volume":"23","author":"HA Fagan","year":"2023","unstructured":"Fagan HA, Baldwin DS. Pharmacological treatment of generalised anxiety disorder: current practice and future directions. Expert Rev Neurother. 2023;23(6):535\u201348. https:\/\/doi.org\/10.1080\/14737175.2023.2211767.","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"5911_CR2","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/14656566.2018.1491966","volume":"19","author":"JR Strawn","year":"2018","unstructured":"Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review. Expert Opin Pharmacother. 2018;19(10):1057\u201370. https:\/\/doi.org\/10.1080\/14656566.2018.1491966.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"5911_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.31887\/DCNS.2017.19.2\/dnutt","volume":"19","author":"E Maron","year":"2017","unstructured":"Maron E, Nutt D. Biological markers of generalized anxiety disorder. Dialogues Clin Neurosci. 2017;19(2):147\u201358. https:\/\/doi.org\/10.31887\/DCNS.2017.19.2\/dnutt.","journal-title":"Dialogues Clin Neurosci"},{"key":"5911_CR4","doi-asserted-by":"publisher","first-page":"e027925","DOI":"10.1136\/bmjopen-2018-027925","volume":"9","author":"H Costello","year":"2019","unstructured":"Costello H, Gould RL, Abrol E, Howard R. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 2019;9:e027925. https:\/\/doi.org\/10.1136\/bmjopen-2018-027925.","journal-title":"BMJ Open"},{"issue":"6","key":"5911_CR5","doi-asserted-by":"publisher","first-page":"326","DOI":"10.9740\/mhc.2020.11.326","volume":"5","author":"ED Ansara","year":"2020","unstructured":"Ansara ED. Management of treatment-resistant generalized anxiety disorder. Ment Health Clin. 2020;5(6):326\u201334. https:\/\/doi.org\/10.9740\/mhc.2020.11.326.","journal-title":"Ment Health Clin"},{"key":"5911_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42:254\u201370. https:\/\/doi.org\/10.1038\/npp.2016.146.","journal-title":"Neuropsychopharmacology"},{"key":"5911_CR7","doi-asserted-by":"crossref","unstructured":"Renna ME, O\u2019Toole MS, Spaeth PE, Lekander M, Mennin DS. The association between anxiety,traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress Anxiety. 2018;;35(11):1081\u20131094. doi: 10.1002\/da.22790.","DOI":"10.1002\/da.22790"},{"issue":"1","key":"5911_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hup.1259","volume":"27","author":"R Hou","year":"2012","unstructured":"Hou R, Baldwin DS. A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol. 2012;27(1):6\u201314.","journal-title":"Hum Psychopharmacol"},{"key":"5911_CR9","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/npp.2010.116","volume":"35","author":"CB Zhu","year":"2010","unstructured":"Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology. 2010;35:2510\u201320.","journal-title":"Neuropsychopharmacology"},{"key":"5911_CR10","doi-asserted-by":"publisher","first-page":"112024","DOI":"10.1016\/j.bbr.2019.112024","volume":"17","author":"S Munshi","year":"2019","unstructured":"Munshi S, Parrilli V, Rosenkranz JA. Peripheral anti-inflammatory cytokine Interleukin-10 treatment mitigates interleukin-1\u03b2 - induced anxiety and sickness behaviors in adult male rats. Behav Brain Res. 2019;17:372:112024. https:\/\/doi.org\/10.1016\/j.bbr.2019.112024.","journal-title":"Behav Brain Res"},{"issue":"6","key":"5911_CR11","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1053\/j.gastro.2010.06.063","volume":"139","author":"P Bercik","year":"2010","unstructured":"Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology. 2010;139(6):2102\u2013e21121. https:\/\/doi.org\/10.1053\/j.gastro.2010.06.063.","journal-title":"Gastroenterology"},{"key":"5911_CR12","doi-asserted-by":"publisher","unstructured":"Gentile A, Fresegna D, Musella A, Sepman H, Bullitta S, De Vito F et al. Interaction between interleukin-1\u03b2 and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2016;13(1):231. Published 2016 Sep 2. https:\/\/doi.org\/10.1186\/s12974-016-0682-8.","DOI":"10.1186\/s12974-016-0682-8"},{"issue":"2","key":"5911_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.expneurol.2012.07.010","volume":"237","author":"N Haji","year":"2012","unstructured":"Haji N, Mandolesi G, Gentile A, Sacchetti L, Fresegna D, Rossi S, et al. TNF-\u03b1-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol. 2012;237(2):296\u2013303. https:\/\/doi.org\/10.1016\/j.expneurol.2012.07.010.","journal-title":"Exp Neurol"},{"key":"5911_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2019.06.001","volume":"81","author":"R Hou","year":"2019","unstructured":"Hou R, Ye G, Liu Y, Chen X, Pan M, Zhu F, et al. Effects of SSRIs on peripheral inflammatory cytokines in patients with generalized anxiety disorder. Brain Behav Immun. 2019;81:105\u201310. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.001.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5911_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41398-022-01835-y","volume":"12","author":"LA Quagliato","year":"2022","unstructured":"Quagliato LA, Nardi AE. Cytokine profile in drug-na\u00efve panic disorder patients. Transl Psychiatry. 2022;12(1):75. https:\/\/doi.org\/10.1038\/s41398-022-01835-y. Published 2022 Feb 22.","journal-title":"Transl Psychiatry"},{"key":"5911_CR16","doi-asserted-by":"publisher","first-page":"3501905","DOI":"10.1155\/2016\/3501905","volume":"2016","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Park HJ, Starkweather A, An K, Shim I. Decreased Interleukin-4 release from the neurons of the Locus Coeruleus in response to immobilization stress. Mediators Inflamm. 2016;2016:3501905. https:\/\/doi.org\/10.1155\/2016\/3501905.","journal-title":"Mediators Inflamm"},{"issue":"10","key":"5911_CR17","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s00213-019-5186-7","volume":"236","author":"T Gao","year":"2019","unstructured":"Gao T, Li B, Hou Y, Luo S, Feng L, Nie J, et al. Interleukin-4 signalling pathway underlies the anxiolytic effect induced by 3-deoxyadenosine. Psychopharmacology. 2019;236(10):2959\u201373. https:\/\/doi.org\/10.1007\/s00213-019-5186-7.","journal-title":"Psychopharmacology"},{"issue":"4","key":"5911_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10519-015-9714-x","volume":"45","author":"ML Moon","year":"2015","unstructured":"Moon ML, Joesting JJ, Blevins NA, Lawson MA, Gainey SJ, Towers AE, et al. IL-4 knock out mice display anxiety-like Behavior. Behav Genet. 2015;45(4):451\u201360. https:\/\/doi.org\/10.1007\/s10519-015-9714-x.","journal-title":"Behav Genet"},{"key":"5911_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jad.2017.08.082","volume":"225","author":"Z Tang","year":"2018","unstructured":"Tang Z, Ye G, Chen X, Pan M, Fu J, Fu T, et al. Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J Affect Disord. 2018;225:593\u20138. https:\/\/doi.org\/10.1016\/j.jad.2017.08.082.","journal-title":"J Affect Disord"},{"key":"5911_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2017.07.021","volume":"656","author":"CJ Yang","year":"2017","unstructured":"Yang CJ, Liu D, Xu ZS, Shi SX, Du YJ. The pro-inflammatory cytokines, salivary cortisol and alpha-amylase are associated with generalized anxiety disorder (GAD) in patients with asthma. Neurosci Lett. 2017;656:15\u201321. https:\/\/doi.org\/10.1016\/j.neulet.2017.07.021.","journal-title":"Neurosci Lett"},{"issue":"4","key":"5911_CR21","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/tp.2013.27","volume":"3","author":"N Vogelzangs","year":"2013","unstructured":"Vogelzangs N, Beekman AT, de Jonge P, Penninx BW. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):e249. https:\/\/doi.org\/10.1038\/tp.2013.27.","journal-title":"Transl Psychiatry"},{"issue":"1\u20132","key":"5911_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jneuroim.2010.07.018","volume":"229","author":"MM Vieira","year":"2010","unstructured":"Vieira MM, Ferreira TB, Pacheco PA, Barros PO, Almeida CR, Ara\u00fajo-Lima CF, et al. Enhanced Th17 phenotype in individuals with generalized anxiety disorder. J Neuroimmunol. 2010;229(1\u20132):212\u20138. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.018.","journal-title":"J Neuroimmunol"},{"key":"5911_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbi.2017.01.021","volume":"62","author":"R Hou","year":"2017","unstructured":"Hou R, Garner M, Holmes C, Osmond C, Teeling J, Lau L, et al. Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. 2017;62:212\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2017.01.021.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"5911_CR24","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1017\/S0033291712000554","volume":"42","author":"WE Copeland","year":"2012","unstructured":"Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol Med. 2012;42(12):2641\u201350. https:\/\/doi.org\/10.1017\/S0033291712000554.","journal-title":"Psychol Med"},{"issue":"1\u20132","key":"5911_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2011.06.009","volume":"238","author":"TB Ferreira","year":"2011","unstructured":"Ferreira TB, Kasahara TM, Barros PO, Vieira MM, Bittencourt VC, Hygino J, et al. Dopamine up-regulates Th17 phenotype from individuals with generalized anxiety disorder. J Neuroimmunol. 2011;238(1\u20132):58\u201366. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.06.009.","journal-title":"J Neuroimmunol"},{"issue":"18","key":"5911_CR26","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1093\/eurheartj\/ehn326","volume":"29","author":"B Bankier","year":"2008","unstructured":"Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur Heart J. 2008;29(18):2212\u20137. https:\/\/doi.org\/10.1093\/eurheartj\/ehn326.","journal-title":"Eur Heart J"},{"issue":"4","key":"5911_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/cyto.1997.0290","volume":"10","author":"M Maes","year":"1998","unstructured":"Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998;10(4):313\u20138. https:\/\/doi.org\/10.1006\/cyto.1997.0290.","journal-title":"Cytokine"},{"issue":"6","key":"5911_CR28","doi-asserted-by":"publisher","first-page":"e24404","DOI":"10.1002\/jcla.24404","volume":"36","author":"H Lu","year":"2022","unstructured":"Lu H, Yang Q, Zhang Y. The relation of common inflammatory cytokines with anxiety and depression and their values in estimating cardiovascular outcomes in coronary heart disease patients. J Clin Lab Anal. 2022;36(6):e24404. https:\/\/doi.org\/10.1002\/jcla.24404.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"5911_CR29","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2005.06.001","volume":"185","author":"C Pitsavos","year":"2006","unstructured":"Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185(2):320\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.06.001.","journal-title":"Atherosclerosis"},{"key":"5911_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbi.2016.01.003","volume":"57","author":"J Lasselin","year":"2016","unstructured":"Lasselin J, Elsenbruch S, Lekander M, Axelsson J, Karshikoff B, Grigoleit JS, et al. Mood disturbance during experimental endotoxemia: predictors of state anxiety as a psychological component of sickness behavior. Brain Behav Immun. 2016;57:30\u20137. https:\/\/doi.org\/10.1016\/j.bbi.2016.01.003.","journal-title":"Brain Behav Immun"},{"key":"5911_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.bbi.2020.11.007","volume":"91","author":"ZH Zheng","year":"2021","unstructured":"Zheng ZH, Tu JL, Li XH, Hua Q, Liu WZ, Liu Y, et al. Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala. Brain Behav Immun. 2021;91:505\u201318. https:\/\/doi.org\/10.1016\/j.bbi.2020.11.007.","journal-title":"Brain Behav Immun"},{"key":"5911_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2023.03.025","volume":"111","author":"D Mongan","year":"2023","unstructured":"Mongan D, Raj SS, F\u00f6cking M, Byrne JF, Zammit S, Cannon M, et al. Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: a nested case-control study. Brain Behav Immun. 2023;111:90\u2013100. https:\/\/doi.org\/10.1016\/j.bbi.2023.03.025.","journal-title":"Brain Behav Immun"},{"key":"5911_CR33","doi-asserted-by":"publisher","first-page":"881241","DOI":"10.3389\/fpsyt.2022.881241","volume":"13","author":"Z Shen","year":"2022","unstructured":"Shen Z, Cui L, Mou S, Ren L, Yuan Y, Shen X, et al. Combining S100B and cytokines as neuro-inflammatory biomarkers for diagnosing generalized anxiety disorder: a proof-of-Concept Study based on machine learning. Front Psychiatry. 2022;13:881241. https:\/\/doi.org\/10.3389\/fpsyt.2022.881241. Published 2022 Jun 22.","journal-title":"Front Psychiatry"},{"key":"5911_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jad.2020.03.123","volume":"270","author":"EN Wagner","year":"2020","unstructured":"Wagner EN, Strippoli MF, Ajdacic-Gross V, Gholam-Rezaee M, Glaus J, Vandeleur C, et al. Generalized anxiety disorder is prospectively Associated with decreased levels of Interleukin-6 and Adiponectin among individuals from the community. J Affect Disord. 2020;270:114\u20137. https:\/\/doi.org\/10.1016\/j.jad.2020.03.123.","journal-title":"J Affect Disord"},{"key":"5911_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross SH, Cantrell DA. Signaling and function of Interleukin-2 in T lymphocytes. Annu Rev Immunol. 2018;36:411\u201333. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053352.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"5911_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0006-8993(01)02056-x","volume":"894","author":"JH Ye","year":"2001","unstructured":"Ye JH, Tao L, Zalcman SS. Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons. Brain Res. 2001;894(2):241\u20138. https:\/\/doi.org\/10.1016\/s0006-8993(01)02056-x.","journal-title":"Brain Res"},{"issue":"2","key":"5911_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.brainres.2005.05.016","volume":"1049","author":"JH Ye","year":"2005","unstructured":"Ye JH, Zalcman SS, Tao L. Kainate-activated currents in the ventral tegmental area of neonatal rats are modulated by interleukin-2. Brain Res. 2005;1049(2):227\u201333. https:\/\/doi.org\/10.1016\/j.brainres.2005.05.016.","journal-title":"Brain Res"},{"key":"5911_CR38","doi-asserted-by":"publisher","first-page":"2632010X2311807","DOI":"10.1177\/2632010X231180797","volume":"16","author":"FI Suhee","year":"2023","unstructured":"Suhee FI, Shahriar M, Islam SMA, Bhuiyan MA, Islam MR. Elevated serum IL-2 levels are Associated with Major Depressive disorder: a case-control study. Clin Pathol. 2023;16:2632010X231180797. https:\/\/doi.org\/10.1177\/2632010X231180797.","journal-title":"Clin Pathol"},{"issue":"5","key":"5911_CR39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, et al. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies. Acta Psychiatr Scand. 2017;135(5):373\u201387. https:\/\/doi.org\/10.1111\/acps.12698.","journal-title":"Acta Psychiatr Scand"},{"key":"5911_CR40","doi-asserted-by":"publisher","first-page":"105817","DOI":"10.1016\/j.nbd.2022.105817","volume":"172","author":"L Gilio","year":"2022","unstructured":"Gilio L, Fresegna D, Gentile A, Guadalupi L, Sanna K, De Vito F, et al. Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis. Neurobiol Dis. 2022;172:105817. https:\/\/doi.org\/10.1016\/j.nbd.2022.105817.","journal-title":"Neurobiol Dis"},{"key":"5911_CR41","doi-asserted-by":"publisher","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","volume":"14","author":"V Carlini","year":"2023","unstructured":"Carlini V, Noonan DM, Abdalalem E, Goletti D, Sansone C, Calabrone L, et al. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front Immunol. 2023;14:1161067. https:\/\/doi.org\/10.3389\/fimmu.2023.1161067. Published 2023 Jun 8.","journal-title":"Front Immunol"},{"issue":"6","key":"5911_CR42","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","volume":"170","author":"DF Fiorentino","year":"1989","unstructured":"Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170(6):2081\u201395. https:\/\/doi.org\/10.1084\/jem.170.6.2081.","journal-title":"J Exp Med"},{"issue":"11","key":"5911_CR43","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","volume":"147","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O\u2019Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147(11):3815\u201322.","journal-title":"J Immunol"},{"issue":"10","key":"5911_CR44","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","volume":"146","author":"DF Fiorentino","year":"1991","unstructured":"Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol. 1991;146(10):3444\u201351.","journal-title":"J Immunol"},{"issue":"6","key":"5911_CR45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","volume":"174","author":"C Bogdan","year":"1991","unstructured":"Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 1991;174(6):1549\u201355. https:\/\/doi.org\/10.1084\/jem.174.6.1549.","journal-title":"J Exp Med"},{"issue":"24","key":"5911_CR46","doi-asserted-by":"publisher","first-page":"8686","DOI":"10.1073\/pnas.0500419102","volume":"102","author":"PJ Murray","year":"2005","unstructured":"Murray PJ. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci U S A. 2005;102(24):8686\u201391. https:\/\/doi.org\/10.1073\/pnas.0500419102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5911_CR47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","volume":"13","author":"D Lobo-Silva","year":"2016","unstructured":"Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 2016;13(1):297. https:\/\/doi.org\/10.1186\/s12974-016-0763-8.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5911_CR48","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva M, Vieira P, O\u2019Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1):e20190418. https:\/\/doi.org\/10.1084\/jem.20190418.","journal-title":"J Exp Med"},{"issue":"5","key":"5911_CR49","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2020.09.018","volume":"53","author":"A Shemer","year":"2020","unstructured":"Shemer A, Scheyltjens I, Frumer GR, Kim JS, Grozovski J, Ayanaw S, et al. Interleukin-10 prevents pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge. Immunity. 2020;53(5):1033\u2013e10497. https:\/\/doi.org\/10.1016\/j.immuni.2020.09.018.","journal-title":"Immunity"},{"issue":"2","key":"5911_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jpsychires.2008.02.004","volume":"43","author":"AR Mesquita","year":"2008","unstructured":"Mesquita AR, Correia-Neves M, Roque S, Castro AG, Vieira P, Pedrosa J, et al. IL-10 modulates depressive-like behavior. J Psychiatr Res. 2008;43(2):89\u201397. https:\/\/doi.org\/10.1016\/j.jpsychires.2008.02.004.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"5911_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharep.2013.08.002","volume":"66","author":"E Obuchowicz","year":"2014","unstructured":"Obuchowicz E, Bielecka AM, Paul-Samojedny M, Pude\u0142ko A, Kowalski J. Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacol Rep. 2014;66(1):34\u201343. https:\/\/doi.org\/10.1016\/j.pharep.2013.08.002.","journal-title":"Pharmacol Rep"},{"issue":"12","key":"5911_CR52","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1152\/japplphysiol.00602.2015","volume":"119","author":"JE Blatteau","year":"2015","unstructured":"Blatteau JE, de Maistre S, Lambrechts K, Abraini J, Risso JJ, Vall\u00e9e N. Fluoxetine stimulates anti-inflammatory IL-10 cytokine production and attenuates sensory deficits in a rat model of decompression sickness. J Appl Physiol (1985). 2015;119(12):1393\u20139. https:\/\/doi.org\/10.1152\/japplphysiol.00602.2015.","journal-title":"J Appl Physiol (1985)"},{"issue":"10","key":"5911_CR53","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"issue":"suppl 2","key":"5911_CR54","doi-asserted-by":"publisher","first-page":"S226","DOI":"10.1016\/S0924-977X(15)30242-X","volume":"25","author":"T Tofani","year":"2015","unstructured":"Tofani T, Mannelli LD, Zanardelli M, et al. An immunologic profile study in drug-naive generalized anxiety non depressed patients: a pilot study. Eur Neuropsychopharmacol. 2015;25(suppl 2):S226.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"5911_CR55","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/00006842-199807000-00015","volume":"60","author":"KB Koh","year":"1998","unstructured":"Koh KB, Lee BK. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom Med. 1998;60(4):479\u201383.","journal-title":"Psychosom Med"},{"issue":"1","key":"5911_CR56","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41467-023-37424-w","volume":"14","author":"A Inaba","year":"2023","unstructured":"Inaba A, Tuong ZK, Zhao TX, et al. Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells. Nat Commun. 2023;14(1):2071. https:\/\/doi.org\/10.1038\/s41467-023-37424-w. Published 2023 Apr 12.","journal-title":"Nat Commun"},{"key":"5911_CR57","doi-asserted-by":"publisher","first-page":"30459","DOI":"10.1038\/srep30459","volume":"6","author":"H Chen","year":"2016","unstructured":"Chen H, Lin W, Zhang Y, Lin L, Chen J, Zeng Y, et al. IL-10 promotes neurite outgrowth and synapse formation in cultured cortical neurons after the oxygen-glucose deprivation via JAK1\/STAT3 pathway. Sci Rep. 2016;6:30459. https:\/\/doi.org\/10.1038\/srep30459. Published 2016 Jul 26.","journal-title":"Sci Rep"},{"key":"5911_CR58","doi-asserted-by":"publisher","first-page":"106078","DOI":"10.1016\/j.nbd.2023.106078","volume":"180","author":"H Pu","year":"2023","unstructured":"Pu H, Wang Y, Yang T, Leak RK, Stetler RA, Yu F, et al. Interleukin-4 mitigates anxiety-like behavior and loss of neurons and fiber tracts in limbic structures in a microglial PPAR\u03b3-dependent manner after traumatic brain injury. Neurobiol Dis. 2023;180:106078. https:\/\/doi.org\/10.1016\/j.nbd.2023.106078.","journal-title":"Neurobiol Dis"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-024-05911-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-024-05911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:03:01Z","timestamp":1718877781000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-024-05911-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5911"],"URL":"https:\/\/doi.org\/10.1186\/s12888-024-05911-z","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"31 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the Research Ethics Committee (REC) of the University of Asia Pacific, Dhaka, Bangladesh (Ref: UAP\/REC\/2023\/202-S). We briefed the objectives of the study to the participants, and informed consent was obtained from each of them. We conducted this investigation following the Helsinki Declaration\u2019s guiding principles.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}